Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Susan Reckling
Authored Articles
Results of Immunohistochemistry and In Situ Hybridization Reliable Indicators of HER2-Positive Status
Susan Reckling
Breast Cancer
,
Personalized Medicine
,
Solid Tumors
March 2013, Highlights
Read Article
HER2 Status Determined by Central Laboratory Testing May Be More Reliable than Routine Local Testing
Susan Reckling
Breast Cancer
,
Personalized Medicine
,
Solid Tumors
March 2013, Highlights
Read Article
Adjuvant Chemotherapy Reduces Local and Regional Tumor Recurrence, Especially for Patients with ER-Negative Breast Cancer
Susan Reckling
Chemotherapy
,
Personalized Medicine
March 2013, Highlights
Read Article
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
3.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma